Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
-
- 畠山 博充
- 北海道大学
書誌事項
- タイトル
- Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
- 著者
- Chung CH, Aulino J, Muldowney NJ, Hatakeyama H, et al
収録刊行物
-
- Ann Oncol 21
-
Ann Oncol 21 864-70, 2010